Self-Management of Buprenorphine/Naloxone Among Online Discussion Board Users

REFERENCES

• Altice, F. L., Mostashari, F., & Friedland, G. H. (2001). Trust and the acceptance of and adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 28(1), 47–58.
   PubMed Web of Science ®Google Scholar
• Altice, F. L., Sullivan, L. E., Smith-Rohrberg, D., Basu, S., Stancliff, S., & Eldred, L. (2006). The potential role of buprenorphine in the treatment of opioid dependence in HIV-Infected individuals and in HIV Infection Prevention. Clinical Infectious Diseases, 43(Suppl. 4), S178–S183.
   Web of Science ®Google Scholar
• Amato, L., Davoli, M., Perucci, C. A., Ferri, M., Faggiano, F., & Mattick, R. P. (2005). An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Availableevidence to inform clinical practice and research. Journal of Substance Abuse Treatment, 28(4), 321–329.
   PubMed Web of Science ®Google Scholar
• Baker, L., Wagner, T. H., Singer, S., & Bundorf, M. (2003). Use of the internet and e-mail for health care information: Results from a national survey. JAMA: The Journal of The American Medical Association, 289(18), 2400–2406.
   PubMed Web of Science ®Google Scholar
• Barney, L. J., Griffiths, K. M., & Banfield, M. A. (2011). Explicit and implicit information needs of people with depression: A qualitative investigation of problems reported on an online depression support forum. Bmc Psychiatry, 11(88). doi:10.1186/1471-244X-11-88
   Google Scholar
• Barratt, M. J., & Lenton, S. (2010). Beyond recruitment? Participatory online research with people who use drugs. International Journal of Internet Research Ethics, 3, 69–86.
   Google Scholar
• Bazazi, A. R., Yokell, M., Fu, J. J., Rich, J. D., & Zaller, N. D. (2011). Illicit use of Buprenorphine/Naloxone among injecting and noninjecting Opioid users. Journal of Addiction Medicine, 5(3), 175–180.
   PubMed Web of Science ®Google Scholar
• Bell, J. (2010). The Global Diversion of Pharmaceutical Drugs. Addiction, 105(9), 1531–1537.
   PubMedGoogle Scholar
• Boyer, E. W., Babu, K. M., Macalino, G. E., & Compton, W. (2007). Self-treatment of opioid withdrawal with a dietary supplement, Kratom. The American Journal on Addictions, 16(5), 352–356.
   PubMed Web of Science ®Google Scholar
• Cunningham, C. O., Giovanniello, A., Li, X., Kunins, H. V., Roose, R. J., & Sohler, N. L. (2011). A comparison of buprenorphine induction strategies: Patient-centered home-based inductions versus standard-of-care office-based inductions. Journal of Substance Abuse Treatment, 40(4), 349–356.
   PubMed Web of Science ®Google Scholar
• Daniulaityte, R., Falck, R., & Carlson, R. G. (2012a). Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids. Drug and Alcohol Dependence, 122(3), 201–207.
   PubMed Web of Science ®Google Scholar
• Daniulaityte, R., Falck, R., & Carlson, R. G. (2012b). “I'm not afraid of those ones just ‘cause they've been prescribed”: Perceptions of risk among illicit users of pharmaceutical opioids. International Journal of Drug Policy, 23(5), 374–384.
   PubMed Web of Science ®Google Scholar
• Daniulaityte, R., Falck, R. S., Wang, J., & Carlson, R. G. (2009). Illicit use of pharmaceutical opioids among young polydrug users in Ohio. Addictive Behaviors, 34(8), 649–653.
   PubMed Web of Science ®Google Scholar
• Dasgupta, N., Bailey, E. J., Cicero, T., Inciardi, J., Parrino, M., Rosenblum, A., … Dart, R. C. (2010). Post-marketing Surveillance of Methadone and Buprenorphine in the United States. Pain Medicine, 11(7), 1078–1091.
   PubMed Web of Science ®Google Scholar
• Daulouede, J. P., Caer, Y., Galland, P., Villeger, P., Brunelle, E., Bachellier, J., … Courty, P. (2010). Preference for buprenorphine/naloxone and buprenorphine among patients receiving buprenorphine maintenance therapy in France: A prospective, multicenter study. Journal of Substance Abuse Treatment, 38(1), 83–89.
   PubMedGoogle Scholar
• Dennis, M., & Scott, C. K. (2007). Managing addiction as a chronic condition. Addiction Science & Clinical Practice, 4(1), 45–55.
   PubMedGoogle Scholar
• Denzin, N. K., & Lincoln, Y. S. (2003). Strategies of qualitative inquiry. New Delhi: SAGE Publications.
   Google Scholar
• Egan, J. E., Netherland, J., Gass, J., Finkelstein, R., Weiss, L., & Collaborative, f. t. B. (2011). Patient perspectives on Buprenorphine/Naloxone Treatment in the context of HIV care. JAIDS Journal of Acquired Immune Deficiency Syndromes, 56, S46–S53 10.1097/QAI.1090b1013e3182097561.
   PubMed Web of Science ®Google Scholar
• Eichenberg, C. (2008). Internet message boards for suicidal people: A typology of users. Cyberpsychology & Behavior, 11(1), 107–113.
   PubMedGoogle Scholar
• Eysenbach, G., & Till, J. E. (2001). Ethical issues in qualitative research on internet communities. British Medical Journal, 323(7321), 1103–1105.
   PubMed Web of Science ®Google Scholar
• Haddad, M. S., Zelenev, A., & Altice, F. L. (2013). Integrating buprenorphine maintenance therapy into federally qualified health centers: Real-world substance abuse treatment outcomes. Drug Alcohol Dependence, 131(1–2), 127–135.
   PubMed Web of Science ®Google Scholar
• Hadert, A., & Rodham, K. (2008). The invisible reality of arthritis: A qualitative analysis of an online message board. Musculoskeletal Care, 6(3), 181–196.
   PubMedGoogle Scholar
• Jodlowski, D., Sharf, B. F., Nguyen, L. C., Haidet, P., & Woodard, L. D. (2007). ‘Screwed for life’: Examining identification and division in addiction narratives. Communication & Medicine, 4(1), 15–26.
   Google Scholar
• Johnson, G., Zastawny, S., & Kulpa, A. (2010). E-message boards for those who self-injure: Implications for E-health. International Journal of Mental Health and Addiction, 8(4), 566–569.
   Google Scholar
• Kenen, R. H., Shapiro, P. J., Friedman, S., & Coyne, J. C. (2007). Peer-support in coping with medical uncertainty: discussion of oophorectomy and hormone replacement therapy on a web-based message board. Psycho-Oncology, 16(8), 763–771.
   PubMedGoogle Scholar
• Larance, B., Degenhardt, L., Lintzeris, N., Winstock, A., & Mattick, R. (2011). Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non-adherence and aberrant medication-related behaviours. Drug and Alcohol Review, 30(3), 236–245.
   PubMed Web of Science ®Google Scholar
• Ling, W., Casadonte, P., Bigelow, G., Kampman, K. M., Patkar, A., Bailey, G. L., … Beebe, K. L. (2010). Buprenorphine implants for treatment of opioid dependence: A randomized controlled trial. Journal of the American Medical Association, 304(14), 1576–1583.
   PubMed Web of Science ®Google Scholar
• Maremmani, I. (2008). When a new drug promotes the integration of treatment modalities: Suboxone and harm reduction. Heroin Addiction and Related Clinical Problems, 10(3), 5–11.
   Google Scholar
• Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database System Review, 16(2), CD002207.
   Google Scholar
• Miller, J. (2007). The other side of trust in health care: Prescribing drugs with the potential for abuse. Bioethics, 21(1), 51–60.
   PubMed Web of Science ®Google Scholar
• Moratti, E., Kashanpour, H., Lombardelli, T., & Maisto, M. (2010). Intravenous misuse of Buprenorphine characteristics and extent among patients undergoing drug maintenance therapy. Clinical Drug Investigation, 30, 3–11.
   PubMedGoogle Scholar
• Morden, A., Jinks, C., & Ong, B. N. (2012). Rethinking ‘risk’ and self-management for chronic illness. Social Theory & Health, 10, 78–99.
   PubMed Web of Science ®Google Scholar
• Murguía, E., Tackett-Gibson, M., & Lessem, A. (2007). Real Drugs in a Virtual World: Drug Discourse and Community Online. Lanham, MD: Lexington Books.
   Google Scholar
• Nambisan, P. (2011). Information seeking and social support in online health communities: impact on patients’ perceived empathy. Journal of the American Medical Informatics Association, 18(3), 298–304.
   PubMed Web of Science ®Google Scholar
• Orizio, G., Schulz, P., Gasparotti, C., Caimi, L., & Gelatti, U. (2010). The World of e-patients: A content analysis of online social networks focusing on diseases. Telemedicine Journal and E-Health, 16(10), 1060–1066.
   PubMedGoogle Scholar
• Ostertag, S., Wright, B. R. E., Broadhead, R. S., & Altice, F. L. (2006). Trust and other characteristics associated with health care utilization by injection drug users. Journal of Drug Issues, 36(4), 953–974.
   Web of Science ®Google Scholar
• Schultz, P. N., Stava, C., Beck, M. L., & Vassilopoulou-Sellin, R. (2003). Internet message board use by patients with cancer and their families. Clinical Journal of Oncology Nursing, 7(6), 663–667.
   PubMedGoogle Scholar
• Schuman-Olivier, Z., Albanese, M., Nelson, S. E., Roland, L., Puopolo, F., Klinker, L., … Shaffer, H. J. (2010). Self-treatment: Illicit buprenorphine use by opioid-dependent treatment seekers. Journal of Substance Abuse Treatment, 39(1), 41–50.
   PubMed Web of Science ®Google Scholar
• Sohler, N. L., Li, X., Kunins, H. V., Sacajiu, G., Giovanniello, A., Whitley, S., … Cunningham, C. O. (2010). Home- versus office-based buprenorphine inductions for opioid-dependent patients. Journal of Substance Abuse Treatment, 38(2), 153–159.
   PubMed Web of Science ®Google Scholar
• Stanos, S. P., Bruckenthal, P., & Barkin, R. L. (2012). Strategies to reduce the tampering and subsequent abuse of long-acting opioids: Potential risks and benefits of formulations with physical or pharmacologic deterrents to tampering. Mayo Clinic Proceedings, 87(7), 683–694.
   PubMed Web of Science ®Google Scholar
• Stimmel, B.. (2011). Buprenorphine in the treatment of Heroin Addiction: Déjà Vu all over again. Journal of Addictive Diseases, 31(1), 1–2.
   Google Scholar
• Strain, E. C., Harrison, J. A., & Bigelow, G. E. (2011). Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble-films. Clinical Pharmacology & Theraputics, 89(3), 443–449.
   PubMedGoogle Scholar
• Vicknasingam, B., Mazlan, M., Schottenfeld, R. S., & Chawarski, M. C. (2010). Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia. Drug and Alcohol Dependence, 111(1–2), 44–49.
   PubMedGoogle Scholar
• Walker, D., & Myrick, F. (2006). Grounded theory: An exploration of process and procedure. Qualitative Health Research, 16(4), 547–559.
   PubMed Web of Science ®Google Scholar
• Wen, K. Y., McTavish, F., Kreps, G., Wise, M., & Gustafson, D. (2011). From diagnosis to death: A case study of coping with breast cancer as seen through online discussion group messages. Journal of Computer-Mediated Communication, 16(2), 331–361.
   PubMed Web of Science ®Google Scholar
• Wish, E. D., Artigiani, E., Billing, A., Hauser, W., Hemberg, J., Shiplet, M., … DuPont, R. L. (2012). The Emerging Buprenorphine Epidemic in the United States. Journal of Addictive Diseases, 31(1), 3–7.
   PubMed Web of Science ®Google Scholar